Endoplasmic Stress Inhibitors for Homocysteine Induced Cardiovascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|18|2704-2708

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.18, 2016-05, pp. : 2704-2708

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of endoplasmic reticulum stress in endothelial dysfunction induced by homocysteine thiolactone

By  

Fundamental & Clinical Pharmacology, Vol. 29, Iss. 3, 2015-06 ,pp. : 252-259

John Wiley & Sons Inc

Access to resources Recommend Favorite

The endoplasmic reticulum in cardiovascular health and disease

By Dudek Elzbieta   Michalak Marek  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 9, 2012-09 ,pp. : 1209-1217

NRC Research Press

Access to resources Recommend Favorite

Targeting endoplasmic reticulum stress in metabolic disease

By Cao Stewart Siyan   Kaufman Randal J  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 4, 2013-04 ,pp. : 437-448

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease

By Sunder-Plassmann G.   Winkelmayer W.C.   Födinger M.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2637-2652

Informa Healthcare

Access to resources Recommend Favorite

Investigational Notch and Hedgehog inhibitors – therapies for cardiovascular disease

By Redmond Eileen M   Guha Shaunta   Walls Dermot   Cahill Paul A  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 12, 2011-12 ,pp. : 1649-1664

Informa Healthcare

Access to resources Recommend Favorite